For: | Ma J, Song XQ. Correlation between cognitive impairment and metabolic imbalance of gut microbiota in patients with schizophrenia. World J Psychiatry 2023; 13(10): 724-731 [PMID: 38058688 DOI: 10.5498/wjp.v13.i10.724] |
---|---|
URL: | https://www.wjgnet.com/2220-3206/full/v13/i10/724.htm |
Number | Citing Articles |
1 |
Ting Kang, Jingyi Zheng, Chao Jiang, Lihua Jin, Cong Li, Bang Chen, Yehua Shen. Amelioration of walnut, peony seed and camellia seed oils againstd-galactose-induced cognitive impairment in mice by regulating gut microbiota. Food & Function 2024; 15(13): 7063 doi: 10.1039/D4FO01409J
|
2 |
Zongxin Ling, Zhiyong Lan, Yiwen Cheng, Xia Liu, Zhimeng Li, Ying Yu, Yuwei Wang, Li Shao, Zhangcheng Zhu, Jie Gao, Wenhui Lei, Wenwen Ding, Rongxian Liao. Altered gut microbiota and systemic immunity in Chinese patients with schizophrenia comorbid with metabolic syndrome. Journal of Translational Medicine 2024; 22(1) doi: 10.1186/s12967-024-05533-9
|
3 |
Hu Zhang, Jiling Liang, Jielun Huang, Minghui Wang, Liangwen Wu, Tong Wu, Ning Chen. Exerkine irisin mitigates cognitive impairment by suppressing gut-brain axis-mediated inflammation. Journal of Advanced Research 2024; doi: 10.1016/j.jare.2024.10.031
|
4 |
Keer Zhou, Ancha Baranova, Hongbao Cao, Jing Sun, Fuquan Zhang. Gut microbiome and schizophrenia: insights from two-sample Mendelian randomization. Schizophrenia 2024; 10(1) doi: 10.1038/s41537-024-00497-7
|